These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18291550)

  • 21. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
    Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
    Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP).
    Dowd SE; Wolcott RD; Sun Y; McKeehan T; Smith E; Rhoads D
    PLoS One; 2008 Oct; 3(10):e3326. PubMed ID: 18833331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.
    Deresinski S
    Clin Infect Dis; 2009 Oct; 49(7):1072-9. PubMed ID: 19725789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections.
    Moore CL; Hingwe A; Donabedian SM; Perri MB; Davis SL; Haque NZ; Reyes K; Vager D; Zervos MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):148-55. PubMed ID: 19394801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.
    Dahabreh IJ; Economopoulos K
    Clin Trials; 2008; 5(2):116-20. PubMed ID: 18375649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
    Shapiro A; Raman S; Johnson M; Piehl M
    N C Med J; 2009; 70(2):102-7. PubMed ID: 19489364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic foot osteomyelitis.
    Hartemann-Heurtier A; Senneville E
    Diabetes Metab; 2008 Apr; 34(2):87-95. PubMed ID: 18242114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controversies in diagnosing and managing osteomyelitis of the foot in diabetes.
    Jeffcoate WJ; Lipsky BA
    Clin Infect Dis; 2004 Aug; 39 Suppl 2():S115-22. PubMed ID: 15306989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diabetic foot osteomyelitis].
    Senneville E
    Rev Prat; 2007 May; 57(9):991-4. PubMed ID: 17695679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Infection of the diabetic foot--appropriate antibiotics and therapeutic strategies].
    Mudríková T; Tkác I
    Vnitr Lek; 1998 Apr; 44(4):245-8. PubMed ID: 9820112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acceptable rates of treatment failure in osteomyelitis involving the diabetic foot: a survey of infectious diseases consultants.
    Perencevich EN; Kaye KS; Strausbaugh LJ; Fisman DN; Harris AD;
    Clin Infect Dis; 2004 Feb; 38(4):476-82. PubMed ID: 14765338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic foot infections: what have we learned in the last 30 years?
    Uçkay I; Aragón-Sánchez J; Lew D; Lipsky BA
    Int J Infect Dis; 2015 Nov; 40():81-91. PubMed ID: 26460089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Infection of the diabetic foot].
    Jeffcoate W; Game F; Hartemann-Heurtier A
    Journ Annu Diabetol Hotel Dieu; 2005; ():131-41. PubMed ID: 16161313
    [No Abstract]   [Full Text] [Related]  

  • 35. Pseudomonal Diabetic Foot Infections: Vive la Différence?
    Uçkay I; Lebowitz D; Kressmann B; von Dach E; Lipsky BA; Gariani K
    Mayo Clin Proc Innov Qual Outcomes; 2022 Jun; 6(3):250-256. PubMed ID: 35634135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic foot infections: recent literature and cornerstones of management.
    Uçkay I; Gariani K; Dubois-Ferrière V; Suvà D; Lipsky BA
    Curr Opin Infect Dis; 2016 Apr; 29(2):145-52. PubMed ID: 26779774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Imaging Tracers for the Infected Diabetic Foot (Nuclear and Optical Imaging).
    Ankrah AO; Klein HC; Elsinga PH
    Curr Pharm Des; 2018; 24(12):1287-1303. PubMed ID: 29484983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clear clinical definitions of failure are needed in studies of diabetic foot infections.
    Simon GL; Liappis AP
    Clin Infect Dis; 2004 Aug; 39(3):437; author reply 437-8. PubMed ID: 15307014
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibiotic treatment of diseases without an evident infectious etiology.
    Ruef C
    Infection; 2006 Dec; 34(6):299. PubMed ID: 17180581
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of absorbable antibiotic-impregnated calcium sulphate pellets in the management of diabetic foot infections.
    Armstrong DG; Findlow AH; Oyibo SO; Boulton AJ
    Diabet Med; 2001 Nov; 18(11):942-3. PubMed ID: 11703445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.